Skip to content
PubMed This is a summary of 46 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 46 referenced papers

Top Authors

Sigbjørn Berentsen
Privatsykehuset Haugesund
Wilma Barcellini
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Bruno Fattizzo
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Robert A. Brodsky
Johns Hopkins University
Ulrich Jäger
Medical University of Vienna
J. V. Dacie
London Postgraduate Medical and Dental Education
Quentin A. Hill
Leeds Teaching Hospitals NHS Trust
Charles H. Packman
Levine Cancer Institute
Marc Michel
Centre Hospitalier Universitaire Henri-Mondor
David J. Kuter
Massachusetts General Hospital

Top Institutions

Ranked by publications Top 10 institutions
03

Leeds Teaching Hospitals NHS Trust

Leeds, United Kingdom

18 papers
04

Privatsykehuset Haugesund

Haugesund, Norway

42 papers
07

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing, China

30 papers
08

Centre Hospitalier Universitaire Henri-Mondor

Créteil, France

34 papers

References

References (46)
  1. 1

    Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.

    DeZern AE, Brodsky RA

    Hematology/oncology clinics of North America 2015; (29(3)):479-94.

    PMID: 26043387
  2. 2

    Autoimmune hemolytic anemia and venous thromboembolism: A systematic review and meta-analysis.

    Ungprasert P, Tanratana P, Srivali N

    Thrombosis research 2015; (136(5)):1013-7.

    PMID: 26359320
  3. 3

    Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemia.

    Kulpa J, Skrabs C, Simanek R, et al.

    Wiener klinische Wochenschrift 2016; (128(7-8)):234-7 doi:10.1007/s00508-015-0863-y.

    PMID: 26404740
  4. 4

    [Autoimmune hemolytic anemia in children].

    Becheur M, Bouslama B, Slama H, Toumi NE

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2015; (22(5-6)):291-8.

    PMID: 26575109
  5. 5

    The Clinical Pictures of Autoimmune Hemolytic Anemia.

    Packman CH

    Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2015; (42(5)):317-24 doi:10.1159/000440656.

    PMID: 26696800
  6. 6

    Difficult to swallow: warm autoimmune hemolytic anemia in a Jehovah's Witness treated with hemoglobin concentrate complicated by achalasia.

    Epperla N, Strouse C, VanSandt AM, Foy P

    Transfusion 2016; (56(7)):1801-6 doi:10.1111/trf.13607.

    PMID: 27062564
  7. 7

    Acrocyanosis revealing chronic lymphocytic leukemia.

    Lesesve JF

    Clinical case reports 2016; (4(4)):404-5 doi:10.1002/ccr3.529.

    PMID: 27099738
  8. 8

    Clinical characteristics and treatment outcomes of primary autoimmune hemolytic anemia: a single center study from South India.

    Prabhu R, Bhaskaran R, Shenoy V, et al.

    Blood research 2016; (51(2)):88-94 doi:10.5045/br.2016.51.2.88.

    PMID: 27382552
  9. 9

    Autoimmune Hemolytic Anemia.

    Liebman HA, Weitz IC

    The Medical clinics of North America 2017; (101(2)):351-359 doi:10.1016/j.mcna.2016.09.007.

    PMID: 28189175
  10. 10

    Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia.

    Giudice V, Rosamilio R, Ferrara I, et al.

    Open medicine (Warsaw, Poland) 2016; (11(1)):374-380 doi:10.1515/med-2016-0068.

    PMID: 28352823
  11. 11

    Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma presenting simultaneously with acquired hemophilia and warm autoimmune hemolytic anemia.

    Williams C, Cable C, Choi J

    Proceedings (Baylor University. Medical Center) 2017; (30(3)):343-345 doi:10.1080/08998280.2017.11929642.

    PMID: 28670081
  12. 12

    Clinical severity in adult warm autoimmune hemolytic anemia and its relationship to antibody specificity.

    Chadebech P, Loustau V, Janvier D, et al.

    Haematologica 2018; (103(1)):e35-e38 doi:10.3324/haematol.2017.175976.

    PMID: 29025905
  13. 13

    A Comprehensive Diagnostic Algorithm for Direct Antiglobulin Test-Negative Autoimmune Hemolytic Anemia Reveals the Relative Ratio of Three Mechanisms in a Single Laboratory.

    Kamesaki T, Kajii E

    Acta haematologica 2018; (140(1)):10-17 doi:10.1159/000488753.

    PMID: 30007985
  14. 14

    Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.

    Leicht HB, Weinig E, Mayer B, et al.

    BMC pharmacology & toxicology 2018; (19(1)):67 doi:10.1186/s40360-018-0257-7.

    PMID: 30359322
  15. 15

    Abdominal pain in combination with an unexplained hemolytic anemia are crucial signs to test for paroxysmal nocturnal hemoglobinuria: A case report.

    Elias NS, Riedl J, Stouten K, et al.

    Clinical case reports 2019; (7(1)):175-179 doi:10.1002/ccr3.1771.

    PMID: 30656036
  16. 16

    Low-dose rituximab in autoimmune hemolytic anemia: 10 years after.

    Fattizzo B, Zaninoni A, Pettine L, et al.

    Blood 2019; (133(9)):996-998 doi:10.1182/blood-2018-12-885228.

    PMID: 30670440
  17. 17

    Treatment of autoimmune hemolytic anemia: real world data from a reference center in Mexico.

    Jaime-Pérez JC, Aguilar-Calderón P, Salazar-Cavazos L, et al.

    Blood research 2019; (54(2)):131-136 doi:10.5045/br.2019.54.2.131.

    PMID: 31309092
  18. 18

    Clinical Features and Treatment Outcomes of Warm Autoimmune Hemolytic Anemia: A Retrospective Analysis of 60 Turkish Patients.

    Yılmaz F, Kiper D, Koç M, et al.

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2019; (35(3)):523-530 doi:10.1007/s12288-019-01103-y.

    PMID: 31388268
  19. 19

    Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease.

    Rivalta B, Zama D, Pancaldi G, et al.

    Frontiers in pediatrics 2019; (7()):304 doi:10.3389/fped.2019.00304.

    PMID: 31396497
  20. 20

    Warm Autoimmune Hemolytic Anemia.

    Brodsky RA

    The New England journal of medicine 2019; (381(7)):647-654 doi:10.1056/NEJMcp1900554.

    PMID: 31412178
  21. 21

    A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia.

    Piatek CI, Bocian H, Algaze S, et al.

    Acta haematologica 2020; (143(3)):244-249 doi:10.1159/000501538.

    PMID: 31665725
  22. 22

    Babesiosis-Associated Warm Autoimmune Hemolytic Anemia.

    Santos MA, Tierney LM, Manesh R

    Journal of general internal medicine 2020; (35(3)):928-929 doi:10.1007/s11606-019-05506-5.

    PMID: 31713032
  23. 23

    Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.

    Jäger U, Barcellini W, Broome CM, et al.

    Blood reviews 2020; (41()):100648 doi:10.1016/j.blre.2019.100648.

    PMID: 31839434
  24. 24

    Role of therapeutic plasma exchanges in refractory severe warm autoimmune hemolytic anemia: Presentation of two case reports.

    García-García I, Cid J, Palomino A, et al.

    Transfusion 2020; (60(11)):2753-2757 doi:10.1111/trf.16143.

    PMID: 33089904
  25. 25

    Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist.

    Fattizzo B, Giannotta JA, Serpenti F, Barcellini W

    Journal of clinical medicine 2020; (9(12)) doi:10.3390/jcm9123858.

    PMID: 33261016
  26. 26

    Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia.

    Gauchy AC, Hentzien M, Wynckel A, et al.

    Clinical case reports 2020; (8(12)):2641-2644 doi:10.1002/ccr3.3250.

    PMID: 33363796
  27. 27

    Epidemiology of Secondary Warm Autoimmune Haemolytic Anaemia-A Systematic Review and Meta-Analysis.

    Tranekær S, Hansen DL, Frederiksen H

    Journal of clinical medicine 2021; (10(6)) doi:10.3390/jcm10061244.

    PMID: 33802848
  28. 28

    Warm Autoimmune Hemolytic Anemia Associated With Asymptomatic SARS-CoV-2 Infection.

    Liput JR, Jordan K, Patadia R, Kander E

    Cureus 2021; (13(3)):e14101 doi:10.7759/cureus.14101.

    PMID: 33927918
  29. 29

    Diagnostic algorithm for classification and characterization of direct antiglobulin test-negative autoimmune hemolytic anemia with 1-year clinical follow-up.

    Kamesaki T

    Transfusion 2022; (62(1)):205-216 doi:10.1111/trf.16709.

    PMID: 34668206
  30. 30

    Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review.

    Autore F, Pasquale R, Innocenti I, et al.

    Cancers 2021; (13(22)) doi:10.3390/cancers13225804.

    PMID: 34830959
  31. 31

    Warm Autoimmune Hemolytic Anemia as the Initial Presentation of Systemic Lupus Erythematosus (SLE): A Case Report.

    Kanderi T, Kim J, Chan Gomez J, et al.

    The American journal of case reports 2021; (22()):e932965 doi:10.12659/AJCR.932965.

    PMID: 34897265
  32. 32

    Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia.

    Yao M, Zhang J, Li Y, et al.

    Medicine 2022; (101(4)):e28679 doi:10.1097/MD.0000000000028679.

    PMID: 35089216
  33. 33

    Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.

    Kuter DJ, Rogers KA, Boxer MA, et al.

    American journal of hematology 2022; (97(6)):691-699 doi:10.1002/ajh.26508.

    PMID: 35179251
  34. 34

    Female adolescent with recurrent anemia and thrombocytopenia: Answers.

    Lozano Chinga M, Afify Z, Lowichik A, et al.

    Pediatric nephrology (Berlin, Germany) 2022; (37(9)):2069-2071 doi:10.1007/s00467-022-05486-5.

    PMID: 35275276
  35. 35

    Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumab.

    Jackson EM, Harper S, Webb GJ, Thomas W

    BMJ case reports 2022; (15(8)) doi:10.1136/bcr-2022-250774.

    PMID: 36107725
  36. 36

    Infrequent Thrombotic Complications in Japanese Patients with Warm Autoimmune Hemolytic Anemia.

    Higuchi T, Hoshi T, Toriyama M, et al.

    Internal medicine (Tokyo, Japan) 2023; (62(10)):1441-1447 doi:10.2169/internalmedicine.0541-22.

    PMID: 36171129
  37. 37

    Warm autoimmune hemolytic anemia and the best treatment strategies.

    Kuter DJ

    Hematology. American Society of Hematology. Education Program 2022; (2022(1)):105-113 doi:10.1182/hematology.2022000405.

    PMID: 36485114
  38. 38

    Antibody based therapeutics for autoimmune hemolytic anemia.

    Cavallaro F, Barcellini W, Fattizzo B

    Expert opinion on biological therapy 2023; (23(12)):1227-1237 doi:10.1080/14712598.2023.2274912.

    PMID: 37874225
  39. 39

    Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study.

    Zhang Z, Hu Q, Yang C, et al.

    Annals of medicine 2023; (55(2)):2282180 doi:10.1080/07853890.2023.2282180.

    PMID: 37967535
  40. 40

    Warm Autoimmune Hemolytic Anemia Secondary to Babesia Microti Infection: A Case Report.

    Bleik P, Matubia V

    Cureus 2023; (15(12)):e50294 doi:10.7759/cureus.50294.

    PMID: 38205493
  41. 41

    Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab.

    Murakhovskaya I, Crivera C, Leon A, et al.

    Annals of hematology 2024; (103(4)):1139-1147 doi:10.1007/s00277-023-05613-8.

    PMID: 38296903
  42. 42

    Evaluation of the Quality and Safety of Venous Thromboembolism Prophylaxis Among Gastroenterology Inpatients at a Tertiary Hospital in Australia.

    van Oosterom N, De Guzman KR, Winckel K, et al.

    Hospital pharmacy 2023; (58(6)):595-604 doi:10.1177/00185787231172385.

    PMID: 38560547
  43. 43

    Diagnosis and management of Evans syndrome in adults: first consensus recommendations.

    Fattizzo B, Marchetti M, Michel M, et al.

    The Lancet. Haematology 2024; (11(8)):e617-e628 doi:10.1016/S2352-3026(24)00144-3.

    PMID: 38968944
  44. 44

    A Case of Coombs-Negative Primary Warm Autoimmune Hemolytic Anemia Due to IgA Antibody That Responded Well to Rituximab and Steroids.

    Gergal Gopalkrishna Rao SR

    Cureus 2024; (16(7)):e63598 doi:10.7759/cureus.63598.

    PMID: 39087199
  45. 45

    Literature review of occurrence, effectiveness, safety, and hospitalization burden of blood transfusion in the management of warm autoimmune hemolytic anemia.

    Barros M, Leon A, Crivera C, et al.

    Hematology (Amsterdam, Netherlands) 2025; (30(1)):2472489 doi:10.1080/16078454.2025.2472489.

    PMID: 40073280
  46. 46

    Management of autoimmune hemolytic anemia.

    Barcellini W, Fattizzo B

    Hematology. American Society of Hematology. Education Program 2025; (2025(1)):305-311 doi:10.1182/hematology.2025000719.

    PMID: 41347987